Simplex Trading
OCUL icon

Simplex Trading’s Ocular Therapeutix OCUL Stock Holding History

Simplex Trading’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.37M Sell
161,300
-34,300
-18% -$327K ﹤0.01% 2171
2025
Q4 		$2.37M Sell
195,600
-56,500
-22% -$686K ﹤0.01% 1836
2025
Q3 		$2.95M Buy
252,100
+96,300
+62% +$1.15M ﹤0.01% 1938
2025
Q2 		$1.45M Buy
155,800
+58,400
+60% +$457K ﹤0.01% 2414
2025
Q1 		$713K Buy
97,400
+22,300
+30% +$171K ﹤0.01% 3024
2024
Q4 		$641K Buy
75,100
+53,400
+246% +$521K ﹤0.01% 3289
2024
Q3 		$188K Buy
21,700
+2,700
+14% +$22.3K ﹤0.01% 4573
2024
Q2 		$129K Sell
19,000
-35,800
-65% -$221K ﹤0.01% 5104
2024
Q1 		$498K Buy
54,800
+41,400
+309% +$294K ﹤0.01% 3870
2023
Q4 		$59K Sell
13,400
-41,800
-76% -$124K ﹤0.01% 5933
2023
Q3 		$173K Buy
55,200
+7,400
+15% +$30.3K ﹤0.01% 4508
2023
Q2 		$246K Buy
47,800
+31,300
+190% +$186K ﹤0.01% 4065
2023
Q1 		$86K Buy
16,500
+12,000
+267% +$57K ﹤0.01% 5319
2022
Q4 		$12K Sell
4,500
-7,000
-61% -$23.2K ﹤0.01% 7377
2022
Q3 		$47K Buy
11,500
+9,900
+619% +$49.9K ﹤0.01% 6536
2022
Q2 		$6K Buy
1,600
+300
+23% +$1.13K ﹤0.01% 8735
2022
Q1 		$6K Sell
1,300
-7,600
-85% -$42.1K ﹤0.01% 9309
2021
Q4 		$62K Sell
8,900
-4,900
-36% -$38.1K ﹤0.01% 6945
2021
Q3 		$197K Sell
13,800
-100
-0.7% -$1.12K ﹤0.01% 5609
2021
Q2 		$197K Buy
+13,900
New +$211K ﹤0.01% 5702
2021
Q1 		– Sell
-256
Closed -$529K – 9668
2020
Q4 		$529K Buy
256
+72
+39% +$1.07K ﹤0.01% 3353
2020
Q3 		$140K Buy
184
+161
+700% +$1.34K ﹤0.01% 4542
2020
Q2 		$19K Sell
23
-603
-96% -$4K ﹤0.01% 6261
2020
Q1 		$309K Buy
626
+259
+71% +$1.28K ﹤0.01% 3124
2019
Q4 		$144K Sell
367
-49
-12% -$170 ﹤0.01% 4102
2019
Q3 		$126K Buy
416
+190
+84% +$849 ﹤0.01% 4071
2019
Q2 		$99K Buy
226
+93
+70% +$344 ﹤0.01% 4203
2019
Q1 		$52K Buy
133
+96
+259% +$386 ﹤0.01% 4977
2018
Q4 		$14K Sell
37
-92
-71% -$507 ﹤0.01% 5619
2018
Q3 		$88K Buy
129
+52
+68% +$326 ﹤0.01% 4562
2018
Q2 		$51K Buy
77
+43
+126% +$295 ﹤0.01% 5039
2018
Q1 		$2K Sell
34
-109
-76% -$613 ﹤0.01% 5318
2017
Q4 		$4K Buy
143
+90
+170% +$460 ﹤0.01% 4719
2017
Q3 		$5K Sell
53
-269
-84% -$1.73K ﹤0.01% 4407
2017
Q2 		$34K Sell
322
-381
-54% -$3.69K ﹤0.01% 2761
2017
Q1 		$64K Buy
703
+656
+1,396% +$5.46K ﹤0.01% 2143
2016
Q4 		$7K Sell
47
-259
-85% -$2.01K ﹤0.01% 4069
2016
Q3 		$22K Buy
306
+126
+70% +$768 ﹤0.01% 2879
2016
Q2 		$6K Buy
180
+115
+177% +$1.14K ﹤0.01% 4096
2016
Q1 		$5K Buy
+65
New +$492 ﹤0.01% 4098

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Simplex Trading's OCUL Position: Q1 2026 in Review

Simplex Trading reduced its Ocular Therapeutix (OCUL) stake by 66% in Q1 2026, selling an estimated $101K and leaving 5,555 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #5944.

Simplex Trading first reported a position in OCUL in Q3 2015 and has held it in 34 quarters since. The position peaked at $829K in Q4 2020. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • Simplex Trading held 5,555 shares of Ocular Therapeutix worth $47K as of Q1 2026.
  • Simplex Trading sold 10,647 Ocular Therapeutix shares in Q1 2026, an estimated $101K.
  • Ocular Therapeutix made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5944 holding.
  • Simplex Trading first reported a position in Ocular Therapeutix in Q3 2015 and has held it in 34 quarters since.
  • Simplex Trading's Ocular Therapeutix position peaked at $829K in Q4 2020.
  • 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.